Found: 45
Select item for more details and to access through your institution.
Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection.
- Published in:
- PLoS Pathogens, 2018, v. 14, n. 2, p. 1, doi. 10.1371/journal.ppat.1006888
- By:
- Publication type:
- Article
Gene signature discovery and systematic validation across diverse clinical cohorts for TB prognosis and response to treatment.
- Published in:
- PLoS Computational Biology, 2023, v. 19, n. 7, p. 1, doi. 10.1371/journal.pcbi.1010770
- By:
- Publication type:
- Article
Vaccine-elicited Human T Cells Recognizing Conserved Protein Regions Inhibit HIV-1.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 2, p. 464, doi. 10.1038/mt.2013.248
- By:
- Publication type:
- Article
Impact of Select Immunologic and Virologic Biomarkers on CD4 Cell Count Decrease in Patients with Chronic HIV-1 Subtype C Infection: Results from Sinikithemba Cohort, Durban, South Africa.
- Published in:
- Clinical Infectious Diseases, 2009, v. 49, n. 6, p. 956, doi. 10.1086/605503
- By:
- Publication type:
- Article
Contribution of Immunological and Virological Factors to Extremely Severe Primary HIV Type 1 Infection.
- Published in:
- Clinical Infectious Diseases, 2009, v. 48, n. 2, p. 229, doi. 10.1086/595704
- By:
- Publication type:
- Article
Identification of Effective Subdominant Anti-HIV-1 CD8+ T Cells Within Entire Post-infection and Post-vaccination Immune Responses.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 2, p. 1, doi. 10.1371/journal.ppat.1004658
- By:
- Publication type:
- Article
HIV-1 Vaccine-Induced T-Cell Reponses Cluster in Epitope Hotspots that Differ from Those Induced in Natural Infection with HIV-1.
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 6, p. 1, doi. 10.1371/journal.ppat.1003404
- By:
- Publication type:
- Article
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).
- Published in:
- Open Forum Infectious Diseases, 2015, v. 2, n. 3, p. 1, doi. 10.1093/ofid/ofv082
- By:
- Publication type:
- Article
Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
HLA class I supertypes: a revised and updated classification.
- Published in:
- BMC Immunology, 2008, v. 9, p. 1, doi. 10.1186/1471-2172-9-1
- By:
- Publication type:
- Article
COMPASS identifies T-cell subsets correlated with clinical outcomes.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 6, p. 610, doi. 10.1038/nbt.3187
- By:
- Publication type:
- Article
A Statistical Framework for Modeling HLA-Dependent T Cell Response Data.
- Published in:
- PLoS Computational Biology, 2007, v. 3, n. 10, p. e188, doi. 10.1371/journal.pcbi.0030188
- By:
- Publication type:
- Article
Extensive HLA class I allele promiscuity among viral CTL epitopes.
- Published in:
- European Journal of Immunology, 2007, v. 37, n. 9, p. 2419, doi. 10.1002/eji.200737365
- By:
- Publication type:
- Article
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial Reveals an Association of Nonspecific Interferon-γ Secretion with Increased HIV-1 Infection Risk: A Cohort-Based Modeling Study.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0108631
- By:
- Publication type:
- Article
MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0043396
- By:
- Publication type:
- Article
Increased Breadth and Depth of Cytotoxic T Lymphocytes Responses against HIV-1-B Nef by Inclusion of Epitope Variant Sequences.
- Published in:
- PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0017969
- By:
- Publication type:
- Article
HLA-Associated Immune Escape Pathways in HIV-1 Subtype B Gag, Pol and Nef Proteins.
- Published in:
- PLoS ONE, 2009, v. 4, n. 8, p. 1, doi. 10.1371/journal.pone.0006687
- By:
- Publication type:
- Article
Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot.".
- Published in:
- Journal of Translational Medicine, 2005, v. 3, p. 20, doi. 10.1186/1479-5876-3-20
- By:
- Publication type:
- Article
T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily.
- Published in:
- International Immunology, 2006, v. 18, n. 7, p. 1179, doi. 10.1093/intimm/dxl052
- By:
- Publication type:
- Article
HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 1, p. 359, doi. 10.1172/JCI60202
- By:
- Publication type:
- Article
Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes.
- Published in:
- Nature Immunology, 2006, v. 7, n. 2, p. 173, doi. 10.1038/ni1281
- By:
- Publication type:
- Article
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0179597
- By:
- Publication type:
- Article
Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.
- Published in:
- PLoS Medicine, 2020, v. 17, n. 5, p. 1, doi. 10.1371/journal.pmed.1003117
- By:
- Publication type:
- Article
Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The defined attenuated Listeria monocytogenes Δmpl2 mutant is an effective oral vaccine carrier to trigger a long-lasting immune response against a mouse fibrosarcoma.
- Published in:
- European Journal of Immunology, 1997, v. 27, n. 6, p. 1570, doi. 10.1002/eji.1830270637
- By:
- Publication type:
- Article
CXCR3 enables recruitment and site-specific bystander activation of memory CD8<sup>+</sup> T cells.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-12980-2
- By:
- Publication type:
- Article
Achieving intracellular cytokine staining assay concordance on two continents to assess HIV vaccine‐induced T‐cell responses.
- Published in:
- Journal of Leukocyte Biology, 2022, v. 112, n. 5, p. 1167, doi. 10.1002/JLB.5MA0522-668R
- By:
- Publication type:
- Article
HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders.
- Published in:
- Nature Medicine, 2015, v. 21, n. 10, p. 1139, doi. 10.1038/nm.3932
- By:
- Publication type:
- Article
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.
- Published in:
- Nature Medicine, 2011, v. 17, n. 3, p. 366, doi. 10.1038/nm.2316
- By:
- Publication type:
- Article
Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 11, p. 1, doi. 10.1371/journal.ppat.1010016
- By:
- Publication type:
- Article
Host Genetic Determinants of T Cell Responses to the MRKAd5 HIV-1 gag/pol/nef Vaccine in the Step Trial.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. 6, p. 773, doi. 10.1093/infdis/jiq125
- By:
- Publication type:
- Article
Differential Targeting and Shifts in the Immunodominance of Epstein-Barr Virus--Specific CD8 and CD4 T Cell Responses during Acute and Persistent Infection.
- Published in:
- Journal of Infectious Diseases, 2005, v. 192, n. 9, p. 1513, doi. 10.1086/491741
- By:
- Publication type:
- Article
Listeriolysin O: cholesterol inhibits cytolysis but not binding to cellular membranes.
- Published in:
- Molecular Microbiology, 1998, v. 28, n. 6, p. 1081, doi. 10.1046/j.1365-2958.1998.00858.x
- By:
- Publication type:
- Article
Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study.
- Published in:
- PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0152038
- By:
- Publication type:
- Article
Pooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine Efficacy Trials.
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0147812
- By:
- Publication type:
- Article
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Lower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Vaccine-Induced Gag-Specific T Cells Are Associated With Reduced Viremia After HIV-1 Infection.
- Published in:
- Journal of Infectious Diseases, 2013, v. 208, n. 8, p. 1231, doi. 10.1093/infdis/jit322
- By:
- Publication type:
- Article
Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001).
- Published in:
- Journal of Infectious Diseases, 2013, v. 207, n. 2, p. 248, doi. 10.1093/infdis/jis671
- By:
- Publication type:
- Article
Trivalent Adenovirus Type 5 HIV Recombinant Vaccine Primes for Modest Cytotoxic Capacity That Is Greatest in Humans with Protective HLA Class I Alleles.
- Published in:
- PLoS Pathogens, 2011, v. 7, n. 2, p. 1, doi. 10.1371/journal.ppat.1002002
- By:
- Publication type:
- Article
Evidence of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1.
- Published in:
- PLoS Pathogens, 2007, v. 3, n. 7, p. e94, doi. 10.1371/journal.ppat.0030094
- By:
- Publication type:
- Article